Welcome to our dedicated page for Nature’S Sun news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature’S Sun stock.
Nature’s Sunshine Products, Inc. reports company developments tied to its global natural health and wellness business, including herbal and nutritional supplements, personal care products, and its Synergy Worldwide division. News commonly covers quarterly results, gross margin and volume incentive trends, digital commerce, customer acquisition, auto-ship subscription programs, and performance across markets such as Asia, North America, Europe and Latin America.
Company updates also include executive appointments, supply chain and technology initiatives, and product-level announcements such as Pro-Argi-9+, Synergy’s L-arginine supplement for nitric oxide and circulation support.
Nature's Sunshine (Nasdaq: NATR) reported Q1 2026 net sales of $122.9M, up 9%, GAAP EPS of $0.29 (up 16%), and Adjusted EBITDA of $14.6M, up 33%. Gross margin rose to 73.2%. Cash and cash equivalents were $87.6M with zero debt. Company repurchased 20,000 shares for $0.5M and reiterated 2026 guidance: $500–$515M net sales and $50–$54M adjusted EBITDA.
Nature’s Sunshine (NASDAQ: NATR) appointed John Hnanicek as Chief Technology Officer, effective May 4, 2026. He brings decades of senior technology, digital innovation, and e-commerce transformation experience, most recently as Chief Digital Innovation Officer at Melaleuca and prior senior roles at The Vitamin Shoppe.
Hnanicek will lead technology modernization, customer and consultant experience improvements, and support Nature’s Sunshine’s long-term growth strategy, reporting to the company’s executive leadership.
Nature’s Sunshine (Nasdaq: NATR) will host a conference call on Thursday, May 7, 2026 at 5:00 p.m. ET (3:00 p.m. MT) to discuss first-quarter results for the period ended March 31, 2026.
CEO Kenneth Romanzi and CFO Shane Jones will lead the call. A live webcast and replay will be available; replay runs through May 21, 2026.
Nature's Sunshine (Nasdaq: NATR) reported fourth quarter and full year 2025 results, with full year net sales of $480.1M (up 5.7%) and GAAP net income of $19.5M or $1.06 per diluted share. Adjusted EBITDA rose to $49.4M (+21.7%).
Q4 net sales were $123.8M (+4.7%), Q4 GAAP net income was $4.1M and cash was $93.9M with no debt. 2026 guidance: net sales $500–$515M; adjusted EBITDA $50–$54M.
Nature’s Sunshine (Nasdaq: NATR) will hold a conference call on Tuesday, March 10, 2026 at 5:00 p.m. Eastern / 3:00 p.m. Mountain to discuss fourth-quarter and full-year results for the period ended December 31, 2025.
CEO Kenneth Romanzi and CFO Shane Jones will host the call; a press release will precede the call and a replay will be available through March 24, 2026.
Nature's Sunshine (NASDAQ:NATR) division Synergy Worldwide announced that Euromonitor International named Pro-Argi-9+ the world’s #1 L-arginine supplement by retail sales value for 2024, based on custom research conducted Sept–Oct 2025.
Pro-Argi-9+ is described as an L-arginine complexer combining l-arginine and l-citrulline with polyphenols and antioxidants to support nitric oxide production, circulation, and cardiovascular wellness. Synergy cites the recognition as validation of its science-based nutrition strategy and global field distribution across Asia Pacific and other markets.
Nature’s Sunshine (NASDAQ: NATR) named Erich Fritz as Executive Vice President, Global Supply Chain, effective December 8, 2025. He will report to CEO Ken Romanzi and brings over 40 years of operations, supply chain, and business development experience across consumer goods firms.
Mr. Fritz joins from Wyandot Snacks, where he served as COO and board member, and previously led supply chain at B&G Foods (oversaw 50+ brands across nine manufacturing facilities) and manufacturing at Ocean Spray (led 12 facilities and construction of a major beverage plant). He holds a BS in Management and is an inventor on several patents.
Nature's Sunshine (Nasdaq: NATR) reported Q3 2025 results with net sales up 12% to $128.3M and GAAP EPS $0.30 versus $0.23 a year earlier. Adjusted EBITDA rose 42% to $15.2M and gross margin improved 200 basis points to 73.3%. Net cash from operations for the nine months was $25.4M, cash and equivalents were $95.6M and the company ended the period with zero debt. The company repurchased 1,129,000 shares for $14.4M year-to-date. Management raised full-year 2025 guidance to $476–$480M net sales and $47–$49M adjusted EBITDA and announced CEO Ken Romanzi's appointment.
Nature’s Sunshine (Nasdaq: NATR) will hold its third quarter 2025 conference call on Thursday, November 6, 2025 at 5:00 p.m. ET (3:00 p.m. MT) to discuss financial results for the quarter ended September 30, 2025.
CEO Kenneth Romanzi and CFO Shane Jones will host the call. The company will release results in a press release prior to the call. Participants should dial in 5–10 minutes early for registration.
- Toll-free dial-in: 1-800-717-1738
- International dial-in: 1-646-307-1865
- Conference ID: 34830
- Replay available after 8:00 p.m. ET on Nov 6, 2025 through Nov 20, 2025 (toll-free replay: 1-844-512-2921, replay ID 1134830)
Nature’s Sunshine (Nasdaq: NATR) appointed Kenneth Romanzi as Chief Executive Officer and member of the board, effective October 29, 2025. The board made a unanimous decision following a comprehensive search. Romanzi joins with extensive CPG leadership experience, including prior roles as President and CEO of B&G Foods where full-year revenue grew from $1.6 billion to $2.0 billion, plus executive positions at Nabisco, Naked Juice/The Ultimate Juice Company, Hasbro, and Ocean Spray.
Management expects Romanzi to accelerate digital empowerment of distributors, expand omnichannel offerings, and drive long-term shareholder value while building on existing momentum under outgoing CEO Terrence Moorehead.